Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
Clinical trial NCT00413270 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT00413270
- Sponsor
- Novartis Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
- Start date
- 2006-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.